Magnetic resonance imaging helps detect breast cancer but does not eliminate need for biopsy

December 07, 2004

A multicenter study of 821 patients referred for breast biopsy based on prior examinations that suggested cancer finds that while magnetic resonance imaging (MRI) distinguishes between benign and malignant breast tumors better than mammography, biopsies are still needed to confirm the diagnosis.

The study, called the International Breast MR Consortium, was carried out in 14 university hospitals in the United States and Europe, including Johns Hopkins, from June 1998 through October 2001. All patients underwent MRI exams prior to breast biopsy.

David Bluemke, M.D., Ph.D., associate professor of radiology at the Johns Hopkins University School of Medicine, led the Hopkins team that examined 200 of the 821 patients enrolled in the study and reviewed data from all study participants. MRI correctly detected cancer in 356 of 404 cancer cases, resulting in a sensitivity of 88.1%. It correctly identified as negative for cancer 281 of 417 cases without cancer, producing a specificity rate of 67.7%, compared to 52.8% for mammography.

While MRI was good at finding cancer, it was less effective in ruling out malignancies, Bluemke says. "People who have an abnormal mammogram need to have biopsies of suspicious lesions," he says. "While MRI aids in determining the extent of the cancer, it is not a substitute for breast biopsy. Importantly, however, the MRI was not adversely affected by factors such as breast density, tumor type or menopausal status, which frequently complicates mammographic interpretations."

Bluemky believes MRI will be most beneficial for patients with difficult to interpret mammograms.
-end-
The study, funded by the National Cancer Institute, is published in the December 8 issue of the Journal of the American Medical Association.

Related web site:
http://www.hopkinsmedicine.org

Johns Hopkins Medicine

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.